Azelastine Nasal — $0 with Membership

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Seasonal Allergies

• Cetirizine
• Fexofenadine
• Loratadine
• Fluticasone Nasal

Other medications in Allergy & Immunology

• Ciclesonide Nasal
• Ipratropium Nasal
• Oxymetazoline Nasal

About Azelastine Nasal

Tired of seasonal sniffles and year-round allergy woes? Azelastine nasal spray offers effective relief for many. At TheDrugClub, we believe managing your allergies shouldn't break the bank. Our members can access essential medications like azelastine nasal with significant savings, often for a $0 co-pay, delivered right to your door.

Azelastine nasal is a powerful prescription medication designed to combat the bothersome symptoms of allergic rhinitis, both seasonal (like hay fever) and perennial (year-round). If you suffer from sneezing, a runny nose, an itchy nose, or nasal congestion due to allergens like pollen, dust mites, or pet dander, azelastine nasal can provide much-needed relief.

How Azelastine Nasal Works

Unlike some other allergy medications, azelastine is an antihistamine that works directly in the nasal passages. When you're exposed to an allergen, your body releases histamine, a chemical that triggers allergy symptoms. Azelastine blocks the action of histamine, reducing inflammation and alleviating your symptoms quickly and effectively. It also has mast cell stabilizing properties, further preventing the release of allergy-causing chemicals. This dual action helps to provide comprehensive relief, often within minutes of use, making it a preferred choice for many allergy sufferers.

Understanding Typical Costs

Managing chronic allergies can be a significant financial burden. The retail price for a prescription of azelastine nasal can

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Azelastine Nasal is approved for (FDA label)

Azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. Azelastine hydrochloride nasal spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. ( 1 )

Source: Read the full FDA label on DailyMed. Label effective date: September 8, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Azelastine Nasal (FDA label)

Azelastine hydrochloride nasal spray is a nasal spray solution. Each spray of azelastine hydrochloride nasal spray delivers a volume of 0.137 mL solution containing 137 mcg of azelastine hydrochloride. Azelastine hydrochloride nasal spray: 137 mcg of azelastine hydrochloride in each 0.137 mL spray. ( 3 )

Source: FDA prescribing information (DailyMed). Set ID: 4f58c203-f649-a18e-aaf3-70b0797652f4. SPL document ID: 1609cf10-ae35-1f3e-0d03-3d7caa05a1ad. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Azelastine Nasal (FDA label)

Use of azelastine hydrochloride nasal spray has been associated with somnolence [see Warnings and Precautions ( 5.1 )]. The most common adverse reactions (≥2% incidence) are: bitter taste, headache, somnolence, dysesthesia, rhinitis, nasal burning, pharyngitis, epistaxis, sinusitis, paroxysmal sneezing, nausea, dry mouth, fatigue, dizziness, and weight increase. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Apotex CORP. at 1-800-706-5575 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect rates observed in practice.

Source: FDA prescribing information (DailyMed). Set ID: 4f58c203-f649-a18e-aaf3-70b0797652f4. SPL document ID: 1609cf10-ae35-1f3e-0d03-3d7caa05a1ad. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Azelastine Nasal (FDA label)

None. None ( 4 )

Source: FDA prescribing information (DailyMed). Set ID: 4f58c203-f649-a18e-aaf3-70b0797652f4. SPL document ID: 1609cf10-ae35-1f3e-0d03-3d7caa05a1ad. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Azelastine Nasal (FDA label)

Somnolence: Avoid engaging in hazardous occupations requiring complete mental alertness such as driving or operating machinery when taking azelastine hydrochloride nasal spray. ( 5.1 ) Alcohol and other central nervous system (CNS) depressants: Avoid concurrent use with azelastine hydrochloride nasal spray because further decreased alertness and impairment of CNS performance may occur. ( 5.1 ) 5.1 Somnolence in Activities Requiring Mental Alertness In clinical trials, the occurrence of somnolence has been reported in some patients taking azelastine hydrochloride nasal spray [see Adverse Reactions ( 6.1 )] . Patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness and motor coordination such as operating machinery or driving a motor vehicle after administration of azelastine hydrochloride nasal spray.

Source: FDA prescribing information (DailyMed). Set ID: 4f58c203-f649-a18e-aaf3-70b0797652f4. SPL document ID: 1609cf10-ae35-1f3e-0d03-3d7caa05a1ad. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Azelastine Nasal (FDA label)

7.1 Central Nervous System Depressants Concurrent use of azelastine hydrochloride nasal spray with alcohol or other central nervous system depressants should be avoided because reductions in alertness and impairment of central nervous system performance may occur [see Warnings and Precautions ( 5.1 )].

Source: FDA prescribing information (DailyMed). Set ID: 4f58c203-f649-a18e-aaf3-70b0797652f4. SPL document ID: 1609cf10-ae35-1f3e-0d03-3d7caa05a1ad. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.